Company profile
Thryv Therapeutics company profile
Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.
Business identity
- Website
- https://thryvtrx.com
- Contact email
- [email protected]
- Phone number
- +1 514 973 0915
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- Kingsey Falls, Quebec, Canada
- Postal code
- H7V 5B7
- Country code
- CA
- Continent
- North America